Description
Palbociclib 100 mg (Paleno) contains palbociclib, a targeted anticancer medicine known as a cyclin-dependent kinase (CDK) 4/6 inhibitor. It is used in combination with hormonal therapy for certain patients with hormone receptor-positive (HR-positive), HER2-negative advanced or metastatic breast cancer.
Palbociclib works by inhibiting CDK4 and CDK6 proteins, which are involved in cell-cycle progression. By blocking these proteins, palbociclib can help slow the growth and division of cancer cells.
Frequently Asked Questions
1. What is Palbociclib 100 mg (Paleno) used for?
Palbociclib is used with hormonal therapy for certain patients with hormone receptor-positive (HR-positive), HER2-negative advanced or metastatic breast cancer.
2. How does Palbociclib work?
Palbociclib blocks CDK4 and CDK6 proteins that help cancer cells progress through the cell cycle, thereby slowing the growth and division of cancer cells.
3. Why are blood tests needed during Palbociclib treatment?
Palbociclib can lower blood cell counts, particularly neutrophils. Regular blood tests help your healthcare team monitor your blood counts and determine whether treatment adjustments are needed.
4. What are common side effects of Palbociclib 100 mg?
Common side effects may include low white blood cell counts, infections, fatigue, nausea, mouth sores, diarrhea, decreased appetite, and hair thinning or hair loss.
5. Can Palbociclib 100 mg be taken with other medicines?
Palbociclib can interact with certain medicines, including some medicines that affect CYP3A enzymes. Tell your oncologist about all medicines and supplements you use before starting treatment.
Additional information
| Active Ingredient (Generic Name): | Palbociclib |
|---|---|
| Manufacturer: | Hetero Drugs Ltd |
| Packaging: | 21 Capsules in 1 bottle |
| Strength: | 100 mg |
| Delivery Time: | 6 To 15 days |
| Pack Size | 21 Capsule/s, 42 Capsule/s, 63 Capsule/s |
